Efficacy of transanal tube for the prevention of anastomotic leakage after rectal cancer surgery: A multicenter prospective randomized controlled trial

Efficacy of transanal tube for the prevention of anastomotic leakage after rectal cancer surgery: A multicenter prospective randomized controlled trial - Efficacy of transanal tube for the prevention of anastomotic leakage after rectal cancer surgery: A multicenter prospective randomized controlled trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024862

Enrollment

130

Registered

2016-11-16

Start date

2016-11-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

The transanal tube is inserted into the anus. The transanal tube is not inserted into the anus.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria were biopsy-proven carcinoma of the rectum located within 15cm above the anal verge, age above 20 years, informed consent and ability to understand the study information.

Exclusion criteria

Exclusion criteria: Exclusion criteria included informed consent not possible, declined consent and uncntorolable managemment of the transanal tube.

Design outcomes

Primary

Measure	Time frame
Anastomotic leakage after rectal surgery	—

Secondary

Measure	Time frame
30-day morbidity and mortality postoperatively	—

Countries

Japan

Contacts

Public ContactKenji Matsuda

Wakayama Medical University Second Department of Surgery

kmatsuda@wakayama-med.ac.jp073-441-0613

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026